Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis
- PMID: 16374461
- DOI: 10.1038/sj.jid.5700068
Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis
Abstract
The SCORTEN, calculated within 24 hours of admission, is a severity-of-illness score validated for toxic epidermal necrolysis and Stevens-Johnson syndrome. Our purpose was to assess the performance of successive SCORTEN during the first 5 days of hospitalization and to determine the influence of admission delay. Charts of 144 patients aged 46.8 years (+/-19.7), admitted to our department (1993-2003) with Stevens-Johnson syndrome or toxic epidermal necrolysis, were reviewed. Successive SCORTEN were compared between deceased patients (n = 28, 19.4%) and survivors (n = 116). The performance of the score (calibration, discrimination) was assessed on days 1-5. All seven SCORTEN variables, on days 1-5, were associated with a higher mortality rate. The SCORTEN rose slightly during hospitalization, with a significant difference between days 1 and 4 (<0.05). Performance of the SCORTEN was good on each day, but slightly better on day 3. The areas under the receiver-operating characteristic curves were above 80%. The admission delay did not differ between deceased patients and survivors. Delay-adjusted SCORTEN was close to the crude SCORTEN. The SCORTEN performance during the first 5 days of hospitalization was excellent, and at its best on day 3. We recommend to compute again the SCORTEN on day 3. The admission delay did not influence prognosis or SCORTEN.
Similar articles
-
Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis.JAMA Dermatol. 2020 Dec 1;156(12):1294-1299. doi: 10.1001/jamadermatol.2020.3654. JAMA Dermatol. 2020. PMID: 33084873 Free PMC article.
-
A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.Int J Dermatol. 2015 Jan;54(1):e18-26. doi: 10.1111/ijd.12466. Int J Dermatol. 2015. PMID: 25534407
-
Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.Dermatology. 2022;238(4):736-744. doi: 10.1159/000520494. Epub 2021 Dec 7. Dermatology. 2022. PMID: 34875648
-
Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.J Am Acad Dermatol. 2013 Aug;69(2):187.e1-16; quiz 203-4. doi: 10.1016/j.jaad.2013.05.002. J Am Acad Dermatol. 2013. PMID: 23866879 Review.
-
Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.J Eur Acad Dermatol Venereol. 2020 Sep;34(9):2066-2077. doi: 10.1111/jdv.16137. Epub 2020 Jan 7. J Eur Acad Dermatol Venereol. 2020. PMID: 31912590
Cited by
-
Letter in Reply: Important Points in Toxic Epidermal Necrolysis Management.Oman Med J. 2019 Jul;34(4):359-360. doi: 10.5001/omj.2019.71. Oman Med J. 2019. PMID: 31360329 Free PMC article. No abstract available.
-
The Clinical Characteristics, Putative Drugs, and Optimal Management of 62 Patients With Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis: A Retrospective Observational Study.Indian Dermatol Online J. 2022 Jan 24;13(1):23-31. doi: 10.4103/idoj.idoj_530_21. eCollection 2022 Jan-Feb. Indian Dermatol Online J. 2022. PMID: 35198464 Free PMC article.
-
Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).Orphanet J Rare Dis. 2018 Apr 10;13(1):56. doi: 10.1186/s13023-018-0793-7. Orphanet J Rare Dis. 2018. PMID: 29636107 Free PMC article.
-
Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.Curr Allergy Asthma Rep. 2018 Mar 24;18(4):26. doi: 10.1007/s11882-018-0778-6. Curr Allergy Asthma Rep. 2018. PMID: 29574562 Review.
-
Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.Ther Adv Drug Saf. 2011 Jun;2(3):87-94. doi: 10.1177/2042098611404094. Ther Adv Drug Saf. 2011. PMID: 25083204 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources